The risk for moderate to severe infection in later childhood was associated with overall infection burden in early life.

No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

Governments worldwide implemented NPIs to control the spread of COVID-19. Many studies used simulations to measure the risk ...